Compounds > naproxen
Page last updated: 2024-09-04

naproxen and Experimental Neoplasms

naproxen has been researched along with Experimental Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Grubbs, CJ; Juliana, MM; Lubet, RA; Miller, MS; Moeinpour, FL; Mohammed, A; Sei, S; Shoemaker, RH; Suen, CS1
Chen, Y; Han, J; Li, D; Li, Z; Liu, M; Liu, Z; Wang, Q; Wang, Z; Zhang, J; Zhao, Y1
Bode, AM; Chen, H; Dong, Z; Grubbs, CJ; Huang, Z; Kim, JE; Kim, MS; Langfald, A; Lim, DY; Lubet, RA1
Bode, AM; Boring, D; Grubbs, CJ; Kim, MS; Lu, Y; Lubet, RA; Margaret Juliana, M; Milne, GL; Nicastro, HL; Steele, VE; You, M1
Balansky, R; D'Oria, C; De Flora, S; Ganchev, G; Iltcheva, M; La Maestra, S; Micale, RT; Steele, VE1

Other Studies

5 other study(ies) available for naproxen and Experimental Neoplasms

ArticleYear
Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers.
    Cancer prevention research (Philadelphia, Pa.), 2020, Volume: 13, Issue:3

    Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Carcinogens; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Naproxen; Neoplasm Recurrence, Local; Neoplasms, Experimental; Pulse Therapy, Drug; Rats; Time Factors; Time-to-Treatment; Urinary Bladder; Urinary Bladder Neoplasms

2020
Naproxen platinum(iv) hybrids inhibiting cycloxygenases and matrix metalloproteinases and causing DNA damage: synthesis and biological evaluation as antitumor agents in vitro and in vivo.
    Dalton transactions (Cambridge, England : 2003), 2020, Apr-28, Volume: 49, Issue:16

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line; Cell Proliferation; Cyclooxygenase 2; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Male; Matrix Metalloproteinases; Mice; Mice, Inbred BALB C; Molecular Structure; Naproxen; Neoplasms, Experimental; Organoplatinum Compounds; Structure-Activity Relationship

2020
Naproxen induces cell-cycle arrest and apoptosis in human urinary bladder cancer cell lines and chemically induced cancers by targeting PI3K.
    Cancer prevention research (Philadelphia, Pa.), 2014, Volume: 7, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Female; Humans; Naproxen; Neoplasms, Experimental; Phosphoinositide-3 Kinase Inhibitors; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms

2014
Preventive effects of NSAIDs, NO-NSAIDs, and NSAIDs plus difluoromethylornithine in a chemically induced urinary bladder cancer model.
    Cancer prevention research (Philadelphia, Pa.), 2014, Volume: 7, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Chemoprevention; Drug Evaluation, Preclinical; Eflornithine; Female; Naproxen; Neoplasms, Experimental; Nitric Oxide; Rats; Rats, Inbred F344; Sulindac; Urinary Bladder Neoplasms

2014
Selective inhibition by aspirin and naproxen of mainstream cigarette smoke-induced genotoxicity and lung tumors in female mice.
    Archives of toxicology, 2016, Volume: 90, Issue:5

    Topics: Animals; Anticarcinogenic Agents; Aspirin; Cell Transformation, Neoplastic; Cyclooxygenase Inhibitors; DNA Damage; Estrogen Receptor Modulators; Female; Lung; Lung Neoplasms; Male; Mice; Naproxen; Neoplasms, Experimental; Risk Factors; Sex Factors; Smoking; Time Factors

2016